435 related articles for article (PubMed ID: 21885599)
1. Proof of principle for transfusion of in vitro-generated red blood cells.
Giarratana MC; Rouard H; Dumont A; Kiger L; Safeukui I; Le Pennec PY; François S; Trugnan G; Peyrard T; Marie T; Jolly S; Hebert N; Mazurier C; Mario N; Harmand L; Lapillonne H; Devaux JY; Douay L
Blood; 2011 Nov; 118(19):5071-9. PubMed ID: 21885599
[TBL] [Abstract][Full Text] [Related]
2. [In vitro generation of mature and functional human red blood cells: a model with multidisciplinary perspectives].
Douay L; Giarratana MC
Bull Acad Natl Med; 2005 May; 189(5):903-13; discussion 914-5. PubMed ID: 16433462
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells.
Giarratana MC; Kobari L; Lapillonne H; Chalmers D; Kiger L; Cynober T; Marden MC; Wajcman H; Douay L
Nat Biotechnol; 2005 Jan; 23(1):69-74. PubMed ID: 15619619
[TBL] [Abstract][Full Text] [Related]
4. Human induced pluripotent stem cells can reach complete terminal maturation: in vivo and in vitro evidence in the erythropoietic differentiation model.
Kobari L; Yates F; Oudrhiri N; Francina A; Kiger L; Mazurier C; Rouzbeh S; El-Nemer W; Hebert N; Giarratana MC; François S; Chapel A; Lapillonne H; Luton D; Bennaceur-Griscelli A; Douay L
Haematologica; 2012 Dec; 97(12):1795-803. PubMed ID: 22733021
[TBL] [Abstract][Full Text] [Related]
5. Biological validation of bio-engineered red blood cell productions.
Giarratana MC; Marie T; Darghouth D; Douay L
Blood Cells Mol Dis; 2013 Feb; 50(2):69-79. PubMed ID: 23040561
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietic properties of human induced pluripotent stem cells-derived red blood cells in immunodeficient mice.
Deng J; Lancelot M; Jajosky R; Deng Q; Deeb K; Saakadze N; Gao Y; Jaye D; Liu S; Stowell SR; Cheng L; Roback JD
Am J Hematol; 2022 Feb; 97(2):194-202. PubMed ID: 34779029
[TBL] [Abstract][Full Text] [Related]
7. Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo.
Neildez-Nguyen TM; Wajcman H; Marden MC; Bensidhoum M; Moncollin V; Giarratana MC; Kobari L; Thierry D; Douay L
Nat Biotechnol; 2002 May; 20(5):467-72. PubMed ID: 11981559
[TBL] [Abstract][Full Text] [Related]
8. The assessment of human erythroid output in NOD/SCID mice reconstituted with human hematopoietic stem cells.
Hayakawa J; Hsieh MM; Anderson DE; Phang O; Uchida N; Washington K; Tisdale JF
Cell Transplant; 2010; 19(11):1465-73. PubMed ID: 21214970
[TBL] [Abstract][Full Text] [Related]
9. [Red blood cell production for transfusion purposes. A stem cell ex vivo fate].
Mazurier C; Douay L
Transfus Clin Biol; 2013 May; 20(2):90-4. PubMed ID: 23601197
[TBL] [Abstract][Full Text] [Related]
10. Concise review: stem cell-derived erythrocytes as upcoming players in blood transfusion.
Zeuner A; Martelli F; Vaglio S; Federici G; Whitsett C; Migliaccio AR
Stem Cells; 2012 Aug; 30(8):1587-96. PubMed ID: 22644674
[TBL] [Abstract][Full Text] [Related]
11. [Cell culture for transfusion purposes: the case of red blood cells].
Douay L
Transfus Clin Biol; 2009 May; 16(2):134-7. PubMed ID: 19375969
[TBL] [Abstract][Full Text] [Related]
12. [Immortalization of erythroid progenitors for in vitro large-scale red cell production].
Caulier A; Guyonneau Harmand L; Garçon L
Transfus Clin Biol; 2017 Sep; 24(3):263-267. PubMed ID: 28736161
[TBL] [Abstract][Full Text] [Related]
13. Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood.
Tanavde VM; Malehorn MT; Lumkul R; Gao Z; Wingard J; Garrett ES; Civin CI
Exp Hematol; 2002 Jul; 30(7):816-23. PubMed ID: 12135681
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of Baboon (
Olivier EN; Wang K; Grossman J; Mahmud N; Bouhassira EE
Cells; 2019 Oct; 8(10):. PubMed ID: 31635069
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Stem Cell-Derived Red Blood Cells as a Transfusion Product Using a Novel Animal Model.
Shah SN; Gelderman MP; Lewis EM; Farrel J; Wood F; Strader MB; Alayash AI; Vostal JG
PLoS One; 2016; 11(12):e0166657. PubMed ID: 27959920
[TBL] [Abstract][Full Text] [Related]
16. [In vitro production of red blood cells for future transfusion medicine].
Kurita R
Rinsho Ketsueki; 2023; 64(6):482-488. PubMed ID: 37407471
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo generation of human red blood cells: a new advance in stem cell engineering.
Douay L; Giarratana MC
Methods Mol Biol; 2009; 482():127-40. PubMed ID: 19089353
[TBL] [Abstract][Full Text] [Related]
18. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells.
Pflumio F; Izac B; Katz A; Shultz LD; Vainchenker W; Coulombel L
Blood; 1996 Nov; 88(10):3731-40. PubMed ID: 8916937
[TBL] [Abstract][Full Text] [Related]
19. Macrophages prevent human red blood cell reconstitution in immunodeficient mice.
Hu Z; Van Rooijen N; Yang YG
Blood; 2011 Nov; 118(22):5938-46. PubMed ID: 21926352
[TBL] [Abstract][Full Text] [Related]
20. Erythrocyte-replaced mouse model for Haemoparasite studies: comparison of NOD/shi-scid and C.B-17/Jcl-scid mouse upon acceptability of human erythrocytes.
Ishihara C; Zamoto A; Tsuji M; Wei Q; Azuma I; Hioki K
J Vet Med Sci; 2003 Aug; 65(8):831-7. PubMed ID: 12951413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
